Efficacy and safety of apixaban versus warfarin in patients with atrial fibrillation and active cancer: insights from the ARISTOTLE trial
Event:
ESC Congress 2016
Topic:
Atrial fibrillation (AF)
Session:
New trends in antithrombotic therapy for atrial fibrillation
